Rock Creek Pharmaceuticals (RCPIQ) Stock Price, News & Analysis

Company Overview

Rock Creek Pharmaceuticals, Inc. was a specialty pharmaceutical company focused on developing products derived from anatabine, a naturally occurring alkaloid found in tobacco and certain other plants. The company investigated anatabine for its potential anti-inflammatory and immune-modulating properties.

Its best-known products included Anatabloc, marketed as a nutritional supplement, and CigRx, a smoking-cessation product. Rock Creek also sponsored research and clinical studies involving anatabine and related compounds, although its products did not become widely established as approved prescription medicines.

The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals in 2013. It was based in the United States and was associated with executive Jonnie R. Williams during much of its operating history. Rock Creek later encountered significant regulatory and financial difficulties and is no longer known as an active operating pharmaceutical business.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:RCPIQ
• Previous Symbol: NASDAQ:RCPI
• CIK: 776008
• Web: www.starscientific.com
• Phone: (844) 727-0727
• Fax: 302-636-5454
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A